Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

98.58 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
95 96 Next >
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
William Blair initiated coverage on Moderna Inc (NASDAQ: MRNA) with a Market Perform rati 
Via Benzinga
Top 5 Momentum Stocks For Higher Profits In 2023
Whether you’re a seasoned investor seeking new avenues for growth or a fresh face in trading, these momentum stocks are worth considering on your journey toward financial success and capitalizing on... 
Via Talk Markets
Dow Jones Hits Milestone: 10th Straight Day In Green, Longest Winning Streak Since Early 2017
Via Benzinga
Merck Receives Positive European Union CHMP Opinion for Gefapixant
From Merck & Co., Inc.
Via Business Wire
Check Out What Whales Are Doing With MRK
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
Peering Into Merck & Co's Recent Short Interest
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)
From Merck & Co., Inc.
Via Business Wire
Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government
Johnson & Johnson (NYSE: JNJ) has reportedly taken legal action against the U.S. 
Via Benzinga
Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
From Merck & Co., Inc.
Via Business Wire
2 Best Biotech Stocks to Buy in July
These are two of the largest pharmaceutical companies on the planet. 
Via The Motley Fool
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
Read the latest report on NanoViricides here. 
Via Benzinga
3 Biotech Stocks for Getting Rich in 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist. 
Via InvestorPlace
7 Safe Stocks to Buy as Fed Gears Up for Disinflation
With a hawkish monetary policy the possible outcome of the Federal Reserve impact, these are the safe stocks to buy right now. 
Via InvestorPlace
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
Why Are Dow Stocks Up Today?
The Dow closed in the green today despite some slight weakness in both the S&P 500 and Nasdaq Composite. Why are Dow stocks up today? 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
Roivant Surges As Roche Reportedly Considers $7 Billion Drug Takeover
The report sent Roivant Sciences higher Friday, but a deal is far from guaranteed. 
Via Investor's Business Daily
3 Penny Stocks to Catapult You Into the Millionaires’ Club
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up! 
Via InvestorPlace
Bernie Sanders Doesn't Own Individual Stocks But His Mutual Fund Holdings Include Stakes In Companies He's Criticized, Including Tesla
U.S. Sen. Bernie Sanders has made waves over the years for targeting the ultra-wealthy, with some of the billionaires accumulating their wealth through stock investments. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger
Infinity Pharmaceuticals Inc (NASDAQ: INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the  
Via Benzinga
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Read the latest report on NanoViricides here. 
Via Benzinga
Retirement Stocks: Here’s Where to Invest $1,000 Right Now
Retirement strategies focus on long-term potential and dividend management. These retirement stocks meet the mark if you have $1,000 today. 
Via InvestorPlace
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
Read the latest report on NanoViricides here. 
Via Benzinga
The 3 Best Dividend ETFs to Buy for July
If you feel some hesitation toward the economic recovery narrative, these best dividend ETFs should help sleep easier at night. 
Via InvestorPlace
Why Shares of Ventyx Biosciences Rose Monday
The company has several promising autoimmune therapies. 
Via The Motley Fool
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
Both companies are facing significant patent cliffs, but they've been preparing for this moment. 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
95 96 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback